[Skip to content]

Royal Brompton & Harefield NHS Foundation Trust
Our research
Search our Site


Films and podcasts about our research

Research: changing lives

Royal Brompton & Harefield NHS Foundation Trust is at the forefront of pioneering research into heart and lung disease; successful research trials can lead to the development of new drugs, treatments and procedures, all aimed at helping improve the lives of patients in the UK and beyond.

Pulmonary hypertension: a discussion into the research by Dr John Wort

Dr John Wort talks more about his research into this disease, what the condition actually is and how the Trust is a leading centre for the treatment of this condition. 

Coronary heart disease: a research journey into 'hard to treat' angina

This podcast features Dr Tina Khan talking about her PhD research into refractory angina - a serious type of angina which is resistant to treatment with medication and revascularisation with stents and/or surgery.


It describes the importance of research into this serious condition; challenges of carrying out research; and how Dr Khan’s research findings may lead to better treatment  options for refractory angina patients in the future.

Idiopathic pulmonary fibrosis; the future of home monitoring in research

This podcast features Dr Toby Maher talking about recently-published research into idiopathic pulmonary fibrosis (IPF), a condition where there is progressive scarring of the lungs.

It explores recent research into home monitoring for IPF and how this is might help with research trials in the future.


Sleep and ventilation research

The Trust runs one of the largest sleep and ventilation services in Europe - find out how our researchers are using innovative methods to improve oxygen intake to the lungs and monitor breathing patterns during sleep.

Idiopathic pulmonary fibrosis (IPF) research

IPF is a growing problem but our research has led to the identification of new markers of progession of this disease.  Together with industry collaboration, this means our patients have access to potentially more promising therapies.


Dilated cardiomyopathy (DCM) research

In 2008, the Trust started a major programme of research into the diagnostic potential of cardiac MR scanning and the genetics of DCM - watch this video to discover the impact of this research on patients and their families.


Gene therapy (heart and lung) research

As the leading centre in Europe, the Trust together with Imperial College aims to effectively treat cystic fibrosis and heart failure.  Our researchers continue to focus on the most effective way of delivering gene therapy in order to deliver effective drugs.